Difference between revisions of "DCE MRI Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
 
(117 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 
{{TOCright}}
 
{{TOCright}}
:Co-chairs: Caroline Chung, MD; Hendrik Laue, PhD
+
:Co-chairs: Hendrik Laue, PhD; James O'Connor, MD, PhD
:Secretary: Susan Stanfa
+
 
* [http://tinyurl.com/QIBA-DCE-MRI-Roster Roster]
+
* [https://docs.google.com/spreadsheets/d/e/2PACX-1vRzQYPdYm51Ak3VYii84CtIDFiYRIylH2IkHQZxdAAjJTAVX4iRqlGl2tety1pnDFKN9kLxoKI-RcoM/pubhtml?gid=1048658726&single=true Roster]
  
  
Line 11: Line 11:
 
*[[Synthetic DCE-MRI Data]]
 
*[[Synthetic DCE-MRI Data]]
  
==Recent DCE MRI Meetings==
 
  
'''Approved call summaries:'''
+
==DCE MRI Meetings==
  
*[[Media:2019_03-04_QIBA_DCE_Biomarker_Cmte_Call_Summary-FINAL.pdf|March 4, 2019]]
+
'''Recently Approved Call Summaries'''
*[[Media:2019_02-18_QIBA_DCE_Biomarker_Cmte_Call_Summary-FINAL.pdf|February 18, 2019]]
+
 
*[[Media:2019_02-04_QIBA_DCE_Biomarker_Cmte_Call_Summary-FINAL.pdf|February 4, 2019]]
+
*[[Media:2023_12-11_QIBA-DCE-MRI_BC_Meeting_Summary-FINAL.pdf|December 11, 2023]]
 +
*[[Media:2023_11-13_QIBA-DCE-MRI_BC_Meeting_Summary-FINAL.pdf|November 13, 2023]]
 +
*[[Media:2023_10-23_QIBA-DCE-MRI_BC_Meeting_Summary-FINAL.pdf|October 23, 2023]]
  
 
'''''[[DCE-MRI BC Call Summaries Archive]]'''''
 
'''''[[DCE-MRI BC Call Summaries Archive]]'''''
 
+
<br />
[[QIBA DCE-MRI Technical Committee Call Summaries]]
+
<br />
 +
* [[QIBA DCE-MRI Technical Committee Call Summaries|DCE-MRI TC Call Summaries Archive 2008-2012]]
 +
* Earlier materials can be found on the [[Perfusion, Diffusion and Flow-MRI tech ctte|PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee]] page
  
 
==Profile Development==
 
==Profile Development==
 
+
*[[Media:QIBA DCE-Profile - v2.0 - Consensus Document.pdf|'''MR DCE-MRI Quantification (DCEMRI-Q) (V.2) - Stage 2: Consensus 2023-12-06''']]
 +
*[[Media: QIBA DCE v2.0-Stage1 Public Comment Profile.pdf| '''MR DCE-MRI Quantification (DCEMRI-Q) (V.2) - Stage 1: Public Comment 2020-12-09''']]
 
*[[Media:Compliance v 1 7.doc|DCE-MRI Profile, Section IV Compliance-AG v1.7]] ''05-21-2014''
 
*[[Media:Compliance v 1 7.doc|DCE-MRI Profile, Section IV Compliance-AG v1.7]] ''05-21-2014''
 
*[[Media:Compliance (2).doc|DCE-MRI Profile, Section IV Compliance-AG]] ''01-22-2014''
 
*[[Media:Compliance (2).doc|DCE-MRI Profile, Section IV Compliance-AG]] ''01-22-2014''
*[[Media:DCEMRIProfile v1 6-20111213.pdf|DCE-MRI Quantification Profile v1.6 2011-12-13]] (''Public comment closed Feb 2012'')
+
*[[Media:DCEMRIProfile v1 6-20111213.pdf|'''DCE-MRI Quantification Profile v1.6 2011-12-13''']]
 
*[[Media:Profile Literature Review 20110427 Rev1.xls|DCE-MRI Profile Supporting Literature Review]] ''Revised 05.02.2011''
 
*[[Media:Profile Literature Review 20110427 Rev1.xls|DCE-MRI Profile Supporting Literature Review]] ''Revised 05.02.2011''
  
 
*[[Tools and recommendation for structured literature review]]
 
*[[Tools and recommendation for structured literature review]]
 
*[[Archived DCE-MRI Profiles]]
 
*[[Archived DCE-MRI Profiles]]
 
  
 
==Reference Materials==
 
==Reference Materials==
Line 44: Line 47:
 
*[[Media:Phantom Study Protocol rev20091028.pdf|DCE-MRI Phantom Study Protocol -- rev20091028]]
 
*[[Media:Phantom Study Protocol rev20091028.pdf|DCE-MRI Phantom Study Protocol -- rev20091028]]
 
*[[Proposed Changes to Acquisition Protocol -- 20090315 - E Jackson‎]]
 
*[[Proposed Changes to Acquisition Protocol -- 20090315 - E Jackson‎]]
 +
  
 
==QIBA Funded Projects==
 
==QIBA Funded Projects==
Line 61: Line 65:
  
 
*[[QIBA Artificial Data Evaluation Software]]
 
*[[QIBA Artificial Data Evaluation Software]]
*[[Media:Development of a Tool to Evaluate Software using Artificial DCE-MRI Data and Statistical Analysis.pdf|Project (J) Development of a Tool to Evaluate Software using Artificial DCE-MRI Data and Statistical Analysis (Fraunhofer MEVIS)]]
+
 
 +
*[[Media:Development of a Tool to Evaluate Software using Artificial DCE-MRI Data and Statistical Analysis.pdf|Project (J) Development of a Tool to Evaluate Software using Artificial DCE-MRI Data and Statistical Analysis (Fraunhofer MEVIS, Germany)]]
 +
 
 +
*[[Media:DCE-MRI Phantom Study to Evaluate the Impact of Parallel Imaging and B1 In-homogeneities at Different MR Field Strengths of 1.0T, 1.5T, and 3.0T.pdf | Project (H) DCE-MRI Phantom Study to Evaluate the Impact of Parallel Imaging and B1 In-homogeneities at Different MR Field Strengths of 1.0T, 1.5T, and 3.0T (University Hospital Cologne, Germany)]]
  
 
====Round 4====
 
====Round 4====
Line 72: Line 79:
  
 
====Round 5====
 
====Round 5====
*[[Media:Aggregated Measures of Agreement for QIB Validation-An Open Source Toolkit.pdf | Project (K) Aggregated Measures of Agreement for QIB Validation-An Open Source Toolkit(Duke University)]]
+
*[[Media:Aggregated Measures of Agreement for QIB Validation-An Open Source Toolkit.pdf | Project (K) Aggregated Measures of Agreement for QIB Validation-An Open Source Toolkit (Duke University)]]
 +
 
 +
====Round 6====
 +
*[[Media:Evaluation of RF Transmit Calibration Options for Quantitative DCE-MRI.pdf | Project (Z) Evaluation of RF Transmit Calibration Options for Quantitative DCE-MRI (University of Southern California)]]
  
 
==Historical Background - Formation of the Group==
 
==Historical Background - Formation of the Group==

Latest revision as of 17:02, 17 January 2024

Co-chairs: Hendrik Laue, PhD; James O'Connor, MD, PhD


Project Snapshot

Develop a quantitative imaging profile for Dynamic Contrast Enhanced MRI.


DCE MRI Meetings

Recently Approved Call Summaries

DCE-MRI BC Call Summaries Archive

Profile Development

Reference Materials


QIBA Funded Projects

Round 1

Round 2

Round 3

Round 4

Round 5

Round 6

Historical Background - Formation of the Group